Sep 7, 2024, 15:31
Potential drug to target a rare childhood brain tumour – ICR
The Institute of Cancer Research (ICR) shared a post on LinkedIn:
“News: Research reveals a potential drug to target a rare childhood brain tumour.
ICR scientists and Dana-Farber Cancer Institute found a key weakness in the tumour cells which could be targeted by ribociclib, a drug already used to treat breast cancer.
Read more about the research, funded by The Brain Tumour Charity.”
Source: The Institute of Cancer Research/LinkedIn
More posts featuring The Institute of Cancer Research on oncodaily.com
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Oct 15, 2024, 12:24
Oct 15, 2024, 12:01
Oct 15, 2024, 11:59
Oct 15, 2024, 11:53
Oct 15, 2024, 11:49
Oct 15, 2024, 10:25
Oct 15, 2024, 08:09
Oct 15, 2024, 00:55